Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?
暂无分享,去创建一个
Susan M. Chang | K. Aldape | W. Yung | M. Prados | M. Gilbert | M. Mehta | F. Lieberman | P. Wen | L. Deangelis | H. Fine | T. Cloughesy | K. Lamborn | L. Abrey | Jennifer L. Clarke | H. Robins | J. Kuhn | Michele M. Ennis | J. Clarke
[1] E. Shaw,et al. Prognostic factors for survival in adult patients with recurrent glioma enrolled onto the new approaches to brain tumor therapy CNS consortium phase I and II clinical trials. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] M J Gleason,et al. Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] Kathleen R. Lamborn,et al. Joint NCCTG and NABTC prognostic factors analysis for high-grade recurrent glioma. , 2010, Neuro-oncology.
[4] Timothy F Cloughesy,et al. Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas. , 2008, Neuro-oncology.
[5] T. Cascino,et al. Response criteria for phase II studies of supratentorial malignant glioma. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.